Skip to main content
Trending storyContinuously updated

OpenAI acquires Orchestra Bio to add drug development AI agents

1 reports1 report sources2 hours agoUpdate

Get up to speed on this story

AI Summary

OpenAI Group PBC has acquired Orchestra Bio, a San Francisco startup whose AI agents help pharmaceutical teams track drug development programs. The deal adds drug discovery and development work to OpenAI's lineup of enterprise AI tools. Orchestra Bio's agents have been available outside research preview since September to eligible organizations under a trusted-access program. The companies did not disclose the purchase price.

AI-generated from reports · 2 hours agoUpdate

Latest updatesOct 21 07:40
OpenAI acquires Orchestra Bio to bring AI agents into drug development

Report timeline

Follow the reports to understand different sides of the story.

Oct 21
  1. SiliconANGLETop Deals
    OpenAI acquires Orchestra Bio to bring AI agents into drug development

    OpenAI Group PBC has acquired Orchestra Bio, a San Francisco startup whose AI agents help pharmaceutical teams track development programs.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing